CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ARGXARGENX SE

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $958.91 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
INSTITUTIONAL OWNERSHIP
Institutional holders542
Shares held32,254,112
Value$25.66B
Percent of shares outstanding52.12%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-03-30 · Alan Armstrong · BUY · $1,001 - $15,000
RECENT NEWS
  • ARGX Stock Sinks as Argenx Scraps Late-Stage Trial
  • Argenx shutters Sjogren's study, losing blockbuster expansion opportunity for Vyvgart
  • Argenx falls after ending late-stage trial for Sjögren's disease therapy
  • Stock Movers: Monte Paschi, Aberdeen, Argenx (Podcast)
  • Argenx halts Sjögren's drug trial
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ARGENX SE (ARGX) · Stock Price, Congress Trades, Institutional Holdings · CatalystPit